HDDO-1756 Bio Equivalence Study

NCT04755894 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias

Interventions

DRUG: HDDO-1756
DRUG: HDDO-17561/HDDO-17562

Sponsor

Hyundai Pharmaceutical Co., LTD.